The important 340B plan, designed to provide discounted pharmaceuticals to safety-net healthcare providers, is experiencing heightened examination by various stakeholders. Concerns revolve around alleged abuse of funds https://340bdrugpricingprogram044756.blog5.net/98361742/the-current-340b-initiative-under-examination-what-s-in-jeopardy